Amber M. Johnson

2.8k citations

44 papers · 1.6k indexed · h-index 20

Impact in

Cancer Research top 5%
- Cancer Genomics and Diagnostics
Oncology top 10%
- HER2/EGFR in Cancer Research

Papers in

Cancer Research 19
- Cancer Genomics and Diagnostics 18
Pharmaceutical Science 3

Co-authors: Richard J. Hooley Funda Meric‐Bernstam Sarina A. Piha‐Paul Ecaterina E. Dumbrava Jordi Rodón Jia Zeng Vijaykumar Holla Ann M. Bailey
Journals: Journal of Medicinal Chemistry (3 papers)Journal of Clinical Oncology (3 papers)Clinical Cancer Research (2 papers)JNCI Journal of the National Cancer Institute (2 papers)JCO Clinical Cancer Informatics (2 papers)
Partner nations: United States China Taiwan

In The Last Decade

Amber M. Johnson

40 papers receiving 1.5k citations

Peers

Countries citing papers authored by Amber M. Johnson

Since Specialization

Citations

This map shows the geographic impact of Amber M. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amber M. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amber M. Johnson more than expected).

Fields of papers citing papers by Amber M. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amber M. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amber M. Johnson. The network helps show where Amber M. Johnson may publish in the future.

Co-authors

The 25 scholars most cited alongside Amber M. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amber M. Johnson Line = papers co-authored together Amber M. Johnson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Synthetic Approaches to the New Drugs Approved during 2023 Journal of Medicinal Chemistry ·Scott P. France, Erick A. Lindsey, Emma L. McInturff, Simon Berritt, Baterdene Ulziibayar, Andrew C. Flick, Sarah J. Fink, Tony Gibson, Kaitlyn Gray, Vasiliki Kosmidou, Amber M. Johnson, 達也河原, Subham Mahapatra, Vincent Jolivet, Zhiyao Zhou	2025	2
2	Clinical characterization and therapeutic outcomes of patients (pts) with colorectal cancer (CRC) harboring somatic BRCA1/2 mutations. Journal of Clinical Oncology ·Deepak Bhamidipati, R.P. Fletcher, Ecaterina E. Dumbrava, Siqing Fu, David S. Hong, Daniel D. Karp, Aung Naing, Shubham Pant, Sarina A. Piha‐Paul, Jordi Rodón, Apostolia M. Tsimberidou, Amber M. Johnson, Michael Sangmin Lee, Arvind Dasari, Kanwal Raghav, Van K. Morris, Michael J. Overman, Scott Kopetz, Funda Meric‐Bernstam, Timothy A. Yap	2024	0
3	Synthetic Approaches to the New Drugs Approved During 2022 Journal of Medicinal Chemistry ·Scott P. France, Erick A. Lindsey, Emma L. McInturff, Simon Berritt, Daniel W. Carney, Baterdene Ulziibayar, Sarah J. Fink, Andrew C. Flick, Tony Gibson, Kaitlyn Gray, Amber M. Johnson, Carolyn A. Leverett, 達也河原, Subham Mahapatra, Vincent Jolivet	2024	15
4	Precision Oncology: Evolving Clinical Trials across Tumor Types Cancers ·I-Wen Song, Henry Hiep Vo, K S V Shivani, Mehmet A. Baysal, Michael Kahle, Amber M. Johnson, Apostolia M. Tsimberidou	2023	20
5	Actionability classification of variants of unknown significance correlates with functional effect npj Precision Oncology ·Amber M. Johnson, Patrick Kwok‐Shing Ng, Michael Kahle, J. Castillo, L. Zhao, A. Badeau, Jia Zeng, Vijaykumar Holla, Thuy M. Vu, Fei Su, Sun‐Hee Kim, 黄小京, Xianli Jiang, Ken Chen, Kenna Shaw, Timothy A. Yap, Jordi Rodón, Gordon B. Mills, Funda Meric‐Bernstam	2023	6
6	Abstract A121: Temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer Molecular Cancer Therapeutics ·Jibran Ahmed, Bettzy Stephen, A. A. Kovalenko, Paul Gonsalves, Ece Kılıç, Muhammad Rizwan Khawaja, Quitéria Pereira. MARIANO, Alpa M. Nick, Maria Gabriela Raso, Maya Lastari, Daniel D. Karp, Sarina A. Piha‐Paul, Anil K. Sood, Chaan S. Ng, Amber M. Johnson, Pamela T. Soliman, Funda Meric‐Bernstam, Karen H. Lu, Aung Naing	2023	1
7	Molecular tumour boards — current and future considerations for precision oncology Nature Reviews Clinical Oncology ·Apostolia M. Tsimberidou, Michael Kahle, Henry Hiep Vo, Mehmet A. Baysal, Amber M. Johnson, Funda Meric‐Bernstam	2023	54
8	Evaluating the Effect of Dye–Dye Interactions of Xanthene-Based Fluorophores in the Fluorosequencing of Peptides Bioconjugate Chemistry ·J. Logan Bachman, Soleimani, Angela M. Bardo, Amber M. Johnson, E. Kondrateva, Sean Gerrin, Rita Jazmin, Jagannath Swaminathan, Brent L. Iverson, Edward M. Marcotte, Eric V. Anslyn	2022	3
9	Rapamycin − mTOR + BRAF = ? Using relational similarity to find therapeutically relevant drug-gene relationships in unstructured text Journal of Biomedical Informatics ·Liu Chong, Amber M. Johnson, Jia Zeng, Vijaykumar Holla, Nora Sánchez, Funda Meric‐Bernstam, Elmer V. Bernstam, Trevor Cohen	2019	3
10	Precision Oncology Decision Support: Current Approaches and Strategies for the Future Clinical Cancer Research ·Katherine C. Kurnit, Ecaterina E. Dumbrava, Beate C. Litzenburger, Yekaterina B. Khotskaya, Amber M. Johnson, Timothy A. Yap, Jordi Rodón, Jia Zeng, Md Abu Shufean, Ann M. Bailey, Nora Sánchez, Vijaykumar Holla, John Mendelsohn, Kenna M. Shaw, Elmer V. Bernstam, Gordon B. Mills, Funda Meric‐Bernstam	2018	41
11	Highly parallel single-molecule identification of proteins in zeptomole-scale mixtures Nature Biotechnology ·Jagannath Swaminathan, Alexander A. Boulgakov, Erik T. Hernandez, Angela M. Bardo, J. Logan Bachman, Asia Perveen, Amber M. Johnson, Eric V. Anslyn, Edward M. Marcotte	2018	138
12	Molecular Landscape ofERBB2/ERBB3Mutated Colorectal Cancer JNCI Journal of the National Cancer Institute ·Jonathan M. Loree, Ann M. Bailey, Amber M. Johnson, Yao Yu, Wenhui Wu, Christopher A. Bristow, Jennifer S. Davis, Kenna Shaw, Russell Broaddus, Kimberly C. Banks, Richard B. Lanman, Funda Meric‐Bernstam, Michael J. Overman, Scott Kopetz, Kanwal Raghav	2018	48
13	Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer Clinical Cancer Research ·Funda Meric‐Bernstam, Amber M. Johnson, Ecaterina E. Dumbrava, Kanwal Raghav, Kavitha Balaji, Wu Weiqin, Rashmi K. Murthy, Jordi Rodón, Sarina A. Piha‐Paul	2018	244
14	“Personalized Cancer Therapy”: A Publicly Available Precision Oncology Resource Cancer Research ·Katherine C. Kurnit, Ann M. Bailey, Jia Zeng, Amber M. Johnson, Md Abu Shufean, Lauren Brusco, Beate C. Litzenburger, Nora Sánchez, Yekaterina B. Khotskaya, Vijaykumar Holla, Liliana Catalina Calle Restrepo, Gordon B. Mills, John Mendelsohn, Elmer V. Bernstam, Kenna Shaw, Funda Meric‐Bernstam	2017	29
15	A Decision Support Framework for Genomically Informed Investigational Cancer Therapy JNCI Journal of the National Cancer Institute ·Funda Meric‐Bernstam, Amber M. Johnson, Vijaykumar Holla, Ann M. Bailey, Lauren Brusco, Ken Chen, Mark J. Routbort, Keyur P. Patel, Jia Zeng, Scott Kopetz, Michael A. Davies, Sarina A. Piha‐Paul, David S. Hong, Agda Karina Eterovic, Apostolia M. Tsimberidou, Russell Broaddus, Elmer V. Bernstam, Kenna Shaw, John Mendelsohn, Gordon B. Mills	2015	139
16	Tailoring Plasmonic Enhanced Upconversion in Single NaYF4:Yb3+/Er3+ Nanocrystals Scientific Reports ·Quan Zhuo-ma, Nasim Mohammadi Estakhri, Amber M. Johnson, Jialing Shou, Mayada Demashkieh, Zhenyu Zhang, Andrea Alù, Victoria NIKULINA, Chih‐Kang Shih	2015	40
17	Hard coral (Porites lobata) extracts and homarine on cytochrome P450 expression in Hawaiian butterflyfishes with different feeding strategies Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology ·Somaya H Saloma, Amber M. Johnson, Deborah J. Gochfeld, Marc Slattery, Gary K. Ostrander, Jon‐Paul Bingham, Daniel Schlenk	2015	4
18	Clinical next generation sequencing to identify actionable aberrations in a phase I program Oncotarget ·Genevieve M. Boland, Sarina A. Piha‐Paul, Vivek Subbiah, Mark J. Routbort, Shelley M. Herbrich, Keith Baggerly, Keyur P. Patel, Lauren Brusco, Chacha Horombe, Aung Naing, Siqing Fu, David S. Hong, Filip Jankú, Amber M. Johnson, Russell R. Broaddus, Raja Luthra, Kenna Shaw, John Mendelsohn, Gordon B. Mills, Funda Meric‐Bernstam	2015	33
19	A Supramolecular Sorting Hat: Stereocontrol in Metal–Ligand Self‐Assembly by Complementary Hydrogen Bonding Angewandte Chemie International Edition ·Michael C. Young, Lauren R. Holloway, Amber M. Johnson, Richard J. Hooley	2014	86
20	LARALink: a web application for cytogenetic linkage analysis Clinical Genetics ·Muhamad Tanzi, Lkhamsaizmaa Davaadorj, Dongdong Wang, Chen Zhao, Bin Yao, D. Liu, Shantel Weinsheimer, M Kobayashi, Amber M. Johnson, Kofi Adotey, Pierre Salles Jean	2005	2

About Amber M. Johnson

Amber M. Johnson is a scholar working on Cancer Research, Pharmaceutical Science, Pathology and Forensic Medicine, Pharmacology and Oncology, having authored 44 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (18 papers), Genomics and Rare Diseases (7 papers), Bioinformatics and Genomic Networks (7 papers), Biomedical Text Mining and Ontologies (5 papers), Genetic factors in colorectal cancer (5 papers), Colorectal Cancer Treatments and Studies (4 papers), BRCA gene mutations in cancer (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). The work is most often cited by research in Cancer Research (402 citations), Oncology (373 citations), Organic Chemistry (302 citations), Inorganic Chemistry (142 citations) and Spectroscopy (147 citations). Amber M. Johnson has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Richard J. Hooley, Funda Meric‐Bernstam, Sarina A. Piha‐Paul, Ecaterina E. Dumbrava, Jordi Rodón, Jia Zeng, Vijaykumar Holla, Ann M. Bailey, Rashmi K. Murthy and Kanwal Raghav. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Clinical Oncology, Clinical Cancer Research, JNCI Journal of the National Cancer Institute and JCO Clinical Cancer Informatics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact